Rheumatoid arthritis (RA) is a complex condition that not only affects the joints but also poses a risk to cardiovascular health. Inflammation plays a significant role in this increased…

Read more: Relationship Between Rheumatoid Arthritis Treatments and Cardiovascular Health

In the quest to find effective treatments for diffuse cutaneous systemic sclerosis (dcSSc), researchers have explored lenabasum, a medication that targets the cannabinoid type 2 receptor. A…

Read more: Lenabasum in Diffuse Cutaneous Systemic Sclerosis: Insights from a Phase 3 Study

A recent ancillary study conducted as part of the MAINRITSAN 2 trial has shed light on the interindividual variability in response to rituximab treatment in patients with antineutrophil…

Read more: Individualized Rituximab Treatment in ANCA-Associated Vasculitides

A recent phase IIa trial conducted in Japan has revealed encouraging outcomes regarding the efficacy and safety of TAS5315, an irreversible covalent Bruton's tyrosine kinase (BTK) inhibitor,…

Read more: An Irreversible Covalent Bruton's Tyrosine Kinase Inhibitor Shows Promising Results in Rheumatoid Arthritis Patients with Methotrexate Resistance: Phase IIa Trial Findings

Inflammatory myopathies (IM) encompass a group of rare systemic diseases characterized by muscle inflammation and weakness. However, variations in reported incidence rates have previously…

Read more: Study Reveals Accurate Incidence Rate and Systemic Nature of Inflammatory Myopathies

Autoimmune inflammatory diseases are a heterogeneous group of over eighty inflammatory disorders with an immune response to self-tissues. As with other viral infections, COVID-19 can cause…

Read more: SARS-CoV-2 vaccines and autoimmune rheumatic diseases: timely information on the COVID-19 landscape